About NVX-CoV2373,BBIBP-COV Vaccine
Class: | Vaccine (Protein Subunit Vaccine)
Use: | Prevention of COVID-19 caused by SARS-CoV-2
Adult dose: | 5 mcg/0.5 ml administered intramuscularly, typically in a two-dose series, with the second dose given 21 days after the first
Pediatric dose: | Safety and efficacy not established for individuals under 18 years; dosing for pediatric populations is under investigation
Side effects: | Common side effects include injection site pain, fatigue, headache, muscle pain, chills, fever, and
Medical Disclaimer
This information is for educational purposes only and should not replace professional medical advice.
Always consult with a licensed healthcare provider or pharmacist in the UAE before taking any medication.
The information presented here is specific to medicines available in UAE pharmacies and is regularly updated
to ensure accuracy for patients and healthcare professionals in the United Arab Emirates.